ALKBH5 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), ALKBH5, an m6A demethylase, inhibits LY6/PLAUR Domain Containing 1 (LYPD1) that is recognized and then stabilized by IGF2BP1 142.